TGTX logo

TG Therapeutics (TGTX) Retained earnings

annual retained earnings:

-$1.53B+$23.38M(+1.51%)
December 31, 2024

Summary

  • As of today (June 23, 2025), TGTX annual retained earnings is -$1.53 billion, with the most recent change of +$23.38 million (+1.51%) on December 31, 2024.
  • During the last 3 years, TGTX annual retained earnings has fallen by -$200.50 million (-15.09%).
  • TGTX annual retained earnings is now -179151.44% below its all-time high of -$853.10 thousand, reached on December 31, 2011.

Performance

TGTX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

quarterly retained earnings:

-$1.52B+$5.06M(+0.33%)
March 1, 2025

Summary

  • As of today (June 23, 2025), TGTX quarterly retained earnings is -$1.52 billion, with the most recent change of +$5.06 million (+0.33%) on March 1, 2025.
  • Over the past year, TGTX quarterly retained earnings has increased by +$934.00 thousand (+0.06%).
  • TGTX quarterly retained earnings is now -178558.31% below its all-time high of -$853.10 thousand, reached on December 31, 2011.

Performance

TGTX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TGTX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.5%+0.1%
3 y3 years-15.1%-9.1%
5 y5 years-118.1%-102.6%

TGTX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.1%+1.5%-9.1%+5.6%
5 y5-year-118.1%+1.5%-102.6%+5.6%
alltimeall time<-9999.0%+1.5%<-9999.0%+5.6%

TGTX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$1.52B(-0.3%)
Dec 2024
-$1.53B(-1.5%)
-$1.53B(-1.5%)
Sep 2024
-
-$1.55B(-0.2%)
Jun 2024
-
-$1.56B(+2.1%)
Mar 2024
-
-$1.53B(-1.8%)
Dec 2023
-$1.55B(+1.7%)
-$1.55B(+3.5%)
Sep 2023
-
-$1.50B(-7.1%)
Jun 2023
-
-$1.61B(+3.0%)
Mar 2023
-
-$1.57B(+2.6%)
Dec 2022
-$1.53B(+14.9%)
-$1.53B(+3.6%)
Sep 2022
-
-$1.47B(+2.5%)
Jun 2022
-
-$1.44B(+2.9%)
Mar 2022
-
-$1.40B(+5.2%)
Dec 2021
-$1.33B(+35.5%)
-$1.33B(+7.6%)
Sep 2021
-
-$1.24B(+7.4%)
Jun 2021
-
-$1.15B(+7.3%)
Mar 2021
-
-$1.07B(+9.2%)
Dec 2020
-$980.60M(+39.8%)
-$980.60M(+9.9%)
Sep 2020
-
-$892.38M(+10.8%)
Jun 2020
-
-$805.22M(+7.0%)
Mar 2020
-
-$752.33M(+7.3%)
Dec 2019
-$701.22M(+32.7%)
-$701.22M(+6.0%)
Sep 2019
-
-$661.64M(+10.3%)
Jun 2019
-
-$599.71M(+6.4%)
Mar 2019
-
-$563.50M(+6.7%)
Dec 2018
-$528.35M(+48.9%)
-$528.35M(+11.4%)
Sep 2018
-
-$474.49M(+7.7%)
Jun 2018
-
-$440.53M(+11.1%)
Mar 2018
-
-$396.39M(+11.7%)
Dec 2017
-$354.86M(+50.1%)
-$354.86M(+9.5%)
Sep 2017
-
-$324.00M(+10.8%)
Jun 2017
-
-$292.47M(+10.7%)
Mar 2017
-
-$264.11M(+11.7%)
Dec 2016
-$236.39M(+49.5%)
-$236.39M(+11.1%)
Sep 2016
-
-$212.71M(+13.2%)
Jun 2016
-
-$187.88M(+9.2%)
Mar 2016
-
-$171.98M(+8.8%)
Dec 2015
-$158.13M(+66.1%)
-$158.13M(+12.5%)
Sep 2015
-
-$140.52M(+10.8%)
Jun 2015
-
-$126.87M(+15.6%)
Mar 2015
-
-$109.76M(+15.3%)
Dec 2014
-$95.19M(+141.6%)
-$95.19M(+24.6%)
Sep 2014
-
-$76.39M(+29.6%)
Jun 2014
-
-$58.94M(+25.5%)
Mar 2014
-
-$46.95M(+19.2%)
Dec 2013
-$39.40M(+108.2%)
-$39.40M(+16.8%)
Sep 2013
-
-$33.74M(+15.6%)
Jun 2013
-
-$29.18M(+29.1%)
Mar 2013
-
-$22.60M(+19.4%)
Dec 2012
-$18.93M(+2118.5%)
-$18.93M(+22.4%)
Sep 2012
-
-$15.47M(+18.9%)
Jun 2012
-
-$13.00M(+17.1%)
Mar 2012
-
-$11.11M(+1202.2%)
Dec 2011
-$853.10K(-98.6%)
-$853.10K(-98.6%)
Sep 2011
-
-$61.01M(+0.9%)
Jun 2011
-
-$60.46M(+5.2%)
Mar 2011
-
-$57.48M(-6.3%)
Dec 2010
-$61.31M
-$61.31M(-0.6%)
DateAnnualQuarterly
Sep 2010
-
-$61.67M(-0.1%)
Jun 2010
-
-$61.72M(-2.9%)
Mar 2010
-
-$63.57M(+2.6%)
Dec 2009
-$61.93M(+4.5%)
-$61.93M(+0.4%)
Sep 2009
-
-$61.71M(+0.7%)
Jun 2009
-
-$61.29M(+2.3%)
Mar 2009
-
-$59.90M(+1.1%)
Dec 2008
-$59.27M(+7.8%)
-$59.27M(-0.2%)
Sep 2008
-
-$59.39M(+2.4%)
Jun 2008
-
-$58.00M(+2.5%)
Mar 2008
-
-$56.56M(+2.8%)
Dec 2007
-$55.00M(+28.0%)
-$55.00M(+3.6%)
Sep 2007
-
-$53.09M(+5.3%)
Jun 2007
-
-$50.43M(+10.7%)
Mar 2007
-
-$45.53M(+6.0%)
Dec 2006
-$42.97M(+29.1%)
-$42.97M(+7.9%)
Sep 2006
-
-$39.84M(+5.0%)
Jun 2006
-
-$37.94M(+5.1%)
Mar 2006
-
-$36.09M(+8.5%)
Dec 2005
-$33.27M(+138.4%)
-$33.27M(+7.7%)
Sep 2005
-
-$30.88M(+6.5%)
Jun 2005
-
-$28.99M(+87.0%)
Mar 2005
-
-$15.51M(+11.1%)
Dec 2004
-$13.96M(+86.7%)
-$13.96M(+15.1%)
Sep 2004
-
-$12.12M(+23.4%)
Jun 2004
-
-$9.82M(+11.9%)
Mar 2004
-
-$8.78M(+17.5%)
Dec 2003
-$7.47M(+583.0%)
-$7.47M(+34.8%)
Sep 2003
-
-$5.55M(+141.9%)
Jun 2003
-
-$2.29M(+51.2%)
Mar 2003
-
-$1.52M(+38.6%)
Dec 2002
-$1.09M(-95.9%)
-$1.09M(-96.1%)
Sep 2002
-
-$27.90M(+2.1%)
Jun 2002
-
-$27.32M(-0.1%)
Mar 2002
-
-$27.35M(+2.3%)
Dec 2001
-$26.73M(+7.7%)
-$26.73M(+2.2%)
Sep 2001
-
-$26.16M(+2.9%)
Jun 2001
-
-$25.43M(+9.1%)
Mar 2001
-
-$23.31M(-6.1%)
Dec 2000
-$24.83M(+32.1%)
-$24.83M(+2.5%)
Sep 2000
-
-$24.23M(+4.2%)
Jun 2000
-
-$23.26M(+15.3%)
Mar 2000
-
-$20.17M(+7.3%)
Dec 1999
-$18.80M(+15.3%)
-$18.80M(+3.3%)
Sep 1999
-
-$18.20M(+1.7%)
Jun 1999
-
-$17.90M(+4.1%)
Mar 1999
-
-$17.20M(+5.5%)
Dec 1998
-$16.30M(+20.7%)
-$16.30M(+7.9%)
Sep 1998
-
-$15.10M(+9.4%)
Jun 1998
-
-$13.80M(-7.4%)
Mar 1998
-
-$14.90M(+10.4%)
Dec 1997
-$13.50M(+60.7%)
-$13.50M(+11.6%)
Sep 1997
-
-$12.10M(+7.1%)
Jun 1997
-
-$11.30M(+20.2%)
Mar 1997
-
-$9.40M(+11.9%)
Dec 1996
-$8.40M
-$8.40M(+12.0%)
Sep 1996
-
-$7.50M(+17.2%)
Jun 1996
-
-$6.40M

FAQ

  • What is TG Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for TG Therapeutics?
  • What is TG Therapeutics annual retained earnings year-on-year change?
  • What is TG Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for TG Therapeutics?
  • What is TG Therapeutics quarterly retained earnings year-on-year change?

What is TG Therapeutics annual retained earnings?

The current annual retained earnings of TGTX is -$1.53B

What is the all time high annual retained earnings for TG Therapeutics?

TG Therapeutics all-time high annual retained earnings is -$853.10K

What is TG Therapeutics annual retained earnings year-on-year change?

Over the past year, TGTX annual retained earnings has changed by +$23.38M (+1.51%)

What is TG Therapeutics quarterly retained earnings?

The current quarterly retained earnings of TGTX is -$1.52B

What is the all time high quarterly retained earnings for TG Therapeutics?

TG Therapeutics all-time high quarterly retained earnings is -$853.10K

What is TG Therapeutics quarterly retained earnings year-on-year change?

Over the past year, TGTX quarterly retained earnings has changed by +$934.00K (+0.06%)
On this page